No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Child
-
Dermatologic Agents / adverse effects*
-
Female
-
Humans
-
Incidence
-
Interleukin-12 / antagonists & inhibitors
-
Interleukin-12 / immunology
-
Interleukin-23 / antagonists & inhibitors
-
Interleukin-23 / immunology
-
Male
-
Middle Aged
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Republic of Korea / epidemiology
-
Risk Assessment
-
Tuberculosis / epidemiology*
-
Tuberculosis / immunology
-
Ustekinumab / adverse effects*
-
Young Adult
Substances
-
Dermatologic Agents
-
Interleukin-23
-
Interleukin-12
-
Ustekinumab